DNA METHYLATION IN DEDIFFERENTIATING PLANT PITH TISSUEDURANTE M; GERI C; CIOMEI M et al.1982; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1982; VOL. 38; NO 4; PP. 451-452; BIBL. 21 REF.Article

Quantification of pyrimidine dimers and apurinic sites in DNAs of uniform lengthCIOMEI, M; SUTHERLAND, B. M; CIARROCHI, G et al.Photochemistry and photobiology. 1984, Vol 39, Num 5, pp 593-596, issn 0031-8655Article

Characterization of the effects of two polysulfonated distamycin a derivatives, PNU145156E and PNU153429, on HIV type 1 Tat proteinCORALLINI, A; BETTI, M; CAPUTO, A et al.AIDS research and human retroviruses. 1998, Vol 14, Num 17, pp 1561-1571, issn 0889-2229Article

New sulfonated distamycin a derivatives with bFGF complexing activityCIOMEI, M; PASTORI, W; MARIANI, M et al.Biochemical pharmacology. 1994, Vol 47, Num 2, pp 295-302, issn 0006-2952Article

In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinomaCIOMEI, M; PASTORI, W; PASTORI, A et al.Anticancer research. 1993, Vol 13, Num 1, pp 75-79, issn 0250-7005Article

A comparison of genome modifications leading to genetic and epigenetic tumorous transformation in Nicotiana spp. tissue culturesDURANTE, M; GERI, C; BUTATTI, M et al.Developmental genetics. 1986, Vol 7, Num 1, pp 51-64, issn 0192-253XArticle

Bombesin receptor antagonists. II, Analogues based on substance P antagonistsRUSCONI, L; DE CASTIGLIONE, R; GOZZINI, L et al.Farmaco (Il) : (1989). 1991, Vol 46, Num 6, pp 725-742Article

Synthesis and cytotoxic activity of alkylidene- and alkyl-substituted camptothecinsCANDIANI, I; BEDESCHI, A; CABRI, W et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 7, pp 847-850, issn 0960-894XArticle

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)CIOMEI, M; PASTORI, W; CAPOLONGO, L et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1504-1508, issn 0007-0920Article

Bombesin receptor antagonists. III, Irreversible alkylating analogues ; melphalan derivativesDE CASTIGLIONE, R; GOZZINI, L; GALANTINI, M et al.Farmaco (Il) : (1989). 1991, Vol 46, Num 6, pp 743-757Article

Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesionsSCOVASSI, A. I; PELLEGATA, N. S; DI STEFANO, L et al.Anticancer research. 2001, Vol 21, Num 4A, pp 2803-2808, issn 0250-7005Article

Inhibitory effect of suramin on receptor binding and cytotoxic activity of tumor necrosis factor αGRAZIOLI, L; ALZANI, R; CIOMEI, M et al.International journal of immunopharmacology. 1992, Vol 14, Num 4, pp 637-642, issn 0192-0561Article

In vitro activity of novel sulphonic derivatives of distamicyn AMARIANI, M; PAIO, A; CIOMEI, M et al.Experientia. Supplementum. 1992, Num 61, pp 455-458, issn 0071-335XArticle

Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell linesDE CUPIS, A; CIOMEI, M; PIRANI, P et al.British journal of pharmacology. 1997, Vol 120, Num 3, pp 537-543, issn 0007-1188Article

Bombesin receptor antagonists. V: New irreversible alkylating analoguesDE CASTIGLIONE, R; GOZZINI, L; GALANTINO, M et al.Il Farmaco (Pavia). 1992, Vol 47, Num 6, pp 855-867, issn 0014-827XArticle

Structural alterations of pathologically or physiologically modified DNACIOMEI, M; SPADARI, S; PEDRALI-NOY, G et al.Nucleic acids research. 1984, Vol 12, Num 4, pp 1977-1989, issn 0305-1048Article